Kyleena vs Paragard: Which IUD to Choose?

Both Kyleena and Paragard are highly effective contraceptives with failure rates <1%, but Paragard offers longer duration (10 years vs 5 years) and is hormone-free, while Kyleena provides superior efficacy (0.1% vs 0.8% failure rate), reduces menstrual bleeding, and is the only option for women with contraindications to copper or estrogen-dependent conditions. 1, 2, 3

Efficacy Comparison

Kyleena demonstrates superior contraceptive effectiveness:

Failure rate: 0.1% (1 in 1,000 women per year) 1
Paragard failure rate: 0.8% (8 in 1,000 women per year) 1
Large European cohort study confirmed levonorgestrel IUDs have 84% lower pregnancy risk compared to copper IUDs (adjusted HR 0.16,95% CI 0.10-0.25) 4
Ectopic pregnancy risk is 74% lower with levonorgestrel IUDs versus copper IUDs (adjusted HR 0.26,95% CI 0.10-0.66) 4

This efficacy difference, while small in absolute terms, becomes clinically meaningful for women at highest risk from unintended pregnancy (cardiac disease, recent transplant, severe diabetes, etc.).

Duration of Use

Paragard provides double the approved duration:

Paragard: FDA-approved for 10 years 3
Kyleena: FDA-approved for 5 years 1, 2

Evidence suggests both devices may be effective beyond their approved durations—Kyleena through 7 years and Paragard through 12 years—though this represents off-label use 5.

Side Effect Profiles: The Critical Differentiator

Kyleena (Levonorgestrel 19.5 mg)

Menstrual effects:

Reduces menstrual bleeding significantly 6
Many users develop amenorrhea (absence of periods) 6
Dramatically reduces dysmenorrhea (painful periods) by 59% (RR 0.41,95% CI 0.34-0.48) 7
Risk of discontinuation due to amenorrhea is 21-fold higher than copper IUD 7

Other hormonal effects:

Headaches, nausea, breast tenderness 8
Hair loss, depression, decreased libido 8
Ovarian cysts 8
Oligomenorrhea (infrequent periods) 8

Paragard (Copper T380A)

Menstrual effects:

Increases menstrual bleeding and cramping, especially initially 6, 8
Bleeding may persist long-term 8
51% lower risk of discontinuation due to increased bleeding compared to pre-insertion baseline 7
Regular menstrual cycles continue 6

Advantages:

No hormonal side effects 3
No systemic absorption 3

Medical Contraindications: When the Choice Is Made for You

Choose Kyleena When Paragard Is Contraindicated:

Paragard is Category 4 (unacceptable risk) for:

Wilson disease (copper metabolism disorder) 1
Copper allergy 2, 3

Choose Paragard When Kyleena Is Contraindicated:

Kyleena is Category 4 (unacceptable risk) for:

Current breast cancer 1
Allergy to levonorgestrel, silicone, or polyethylene 2

Both Are Category 4 (Contraindicated) For:

Current pregnancy 9
Puerperal sepsis or septic abortion 10, 9
Current pelvic inflammatory disease 1
Distorted uterine cavity 1
Cervical, endometrial, or gestational trophoblastic cancer 1
Unexplained vaginal bleeding 1

Special Populations

Postpartum Women:

Both devices are US MEC Category 2 (advantages outweigh risks) for most postpartum women 10
Paragard is Category 1 (no restrictions) if inserted <10 minutes after placental delivery 9
Kyleena is Category 2 in immediate postpartum period 9
Higher expulsion rates with immediate postpartum insertion (10% if placed within 10 minutes), but superior long-term continuation compared to delayed insertion 1

Breastfeeding Women:

Both devices are safe for breastfeeding 1
Neither negatively impacts lactation 1

Nulliparous Women:

Both devices are Category 2 (appropriate for use) 9
No increased infertility risk 9
Both are safe for adolescents 6

Women with Medical Comorbidities:

Both are Category 1 or 2 for most conditions including thromboembolism, cardiovascular disease, diabetes, HIV 1, 6
Critical advantage: neither contains estrogen, making them safe when combined hormonal contraceptives are contraindicated 1

Emergency Contraception Context

If the patient is seeking emergency contraception:

Paragard is the gold standard for emergency contraception (can be placed up to 5 days after unprotected intercourse) 11, 12, 13
Paragard prevents 100% of expected pregnancies when used as emergency contraception 13
Recent data suggest Kyleena may prevent 93-96% of expected pregnancies as emergency contraception, but this remains controversial and not FDA-approved for this indication 12, 13, 14

Clinical Decision Algorithm

Start here:

Does the patient have Wilson disease or copper allergy?
- Yes → Kyleena only
- No → Continue
Does the patient have current breast cancer?
- Yes → Paragard only
- No → Continue
Does the patient desire hormone-free contraception?
- Yes → Paragard
- No → Continue
Does the patient have heavy or painful periods?
- Yes → Kyleena (will reduce bleeding and pain)
- No → Continue
Does the patient want the longest possible duration without replacement?
- Yes → Paragard (10 years vs 5 years)
- No → Continue
Is the patient at extremely high risk from unintended pregnancy (e.g., severe cardiac disease, recent transplant, peripartum cardiomyopathy)?
- Yes → Kyleena (lower failure rate: 0.1% vs 0.8%)
- No → Either device appropriate; shared decision-making based on patient preference regarding menstrual changes

Common Pitfalls to Avoid

Don't assume nulliparity is a contraindication—both devices are appropriate 9, 6
Don't withhold IUDs from adolescents—both are safe and effective 6
Don't remove IUDs for STI treatment—treat the infection with the device in place unless there is pelvic inflammatory disease at time of insertion 6
Don't forget the 21-day window—small increased infection risk exists only in first 21 days after insertion 6
Don't use Kyleena for emergency contraception without counseling that this is off-label and potentially less effective than Paragard 14
Don't place either device if active PID is present—this is Category 4 1

Which intrauterine device is more appropriate for a patient—Kyleena (levonorgestrel) or Paragard (copper)—considering efficacy, duration, side‑effect profile, and contraindications?

Have a follow-up question?